A global leader in digital health technologies which address sub-optimal medication use and improve health outcomes in chronic disease.
Joined July 2015
- Tweets 275
- Following 206
- Followers 281
- Likes 163
103 Photos and videos
Equity analysts MST Access have released a report highlighting Adherium’s major value.
Read the full report: bit.ly/4dK20st
$ADR #Adherium #digitalhealth #respiratoryhealth #asthma #innovation #healthcare
34
Adherium has presented the first dataset from its RPM program, showing only 8.3% of asthma patients demonstrated optimal inhaler technique using objective Hailie® Smartinhaler® data.
Read the ASX release: bit.ly/4u7d7jX
$ADR #RPM #DigitalHealth #Asthma
44
Adherium has appointed John Perry as Chief Commercial Officer to lead integrated global commercial operations and support expansion into value-based respiratory care.
Read the ASX release: bit.ly/4o2vyVL
$ADR #DigitalHealth #RPM #ValueBasedCare
47
May 21
Two independent studies were presented at the ATS 2026 International Conference, featuring data using Adherium’s Hailie® Smartinhaler® technology.
Together, they reinforce the role of objective respiratory monitoring in improving patient outcomes.
🔗 bit.ly/3PYyUMJ
1
6
Today is World Asthma Day. The future of asthma care lies in making invisible visible - using continuous data to better understand and support how patients manage their condition. @Adherium is leading this shift. #WorldAsthmaDay
7
Apr 29
@Adherium has today released its quarterly report for the period ending 31 March 2026, highlighting continued acceleration in recurring RPM revenue and commercial execution.
Read the ASX release: bit.ly/4mY5zy9
1
1
11
Mar 11
Adherium has announced new real-world results from the iCARE study, showing a 67% reduction in hospitalisations and 46% reduction in total cost of care for patients using the Hailie® Smartinhaler® platform.
Read the ASX release: bit.ly/46QwqFv
1
18
Mar 10
@Adherium has released a sales update highlighting continued commercial momentum behind its Hailie® Smartinhaler® platform and Remote Patient Monitoring (RPM) model.
Read the ASX release: bit.ly/4cGfNA1
1
17
Feb 24
CEO Dawn Bitz recently provided an investor update on Adherium’s accelerating commercial progress, interim data from the landmark iCARE Study, and the recently completed capital raise.
Here’s the replay: youtu.be/DRUzspwesKo
1
13
Feb 18
Adherium (ASX:ADR) has announced that it has received firm commitments for a total of $6.70 million under the Placement and institutional component of the Accelerated Pro-Rata Non-Renounceable Entitlement Offer (ANREO).
Read the ASX announcement: bit.ly/4rmeNFz
1
31
Feb 16
Adherium has today announced a capital raising of up to approximately A$7.52 million through a Placement and a 1-for-1.5 pro-rata accelerated non-renounceable Entitlement Offer.
Read the ASX announcement: bit.ly/3OaZXDs
1
16
Feb 13
In this investor update, CEO Dawn Bitz outlines Adherium’s progress in respiratory digital health, highlighting momentum in its remote patient monitoring program and continued growth in recurring revenue.
Watch the presentation: youtu.be/E-yiPMVHMak
11
Today @Adherium (ASX: ADR) hosted an investor lunch featuring CEO @DawnBitz and patient advocate Julia Ovens discussing the large opportunity for respiratory health management in Australia and abroad.
Learn more about Adherium at: adherium.com
16
Jan 30
Adherium releases its December 2025 quarterly report, delivering strong growth across shipments, RPM activations and recurring revenue.
Read the ASX release: bit.ly/49MUKdk
$ADR #Adherium #Hailie #inhaler #COPD #asthma #growth #resipiratoryhealth
1
64